Does anti-Mullerian hormone predict change in menopausal symptoms following risk-reducing salpingo-oophorectomy? A prospective observational study

Author(s):
Vermeulen, R.F.M.; Beurden, M. van; Gaarenstroom, K.N.; Teunis, T.; Kieffer, J.M.; Aaronson, N.K.; Kenter, G.G.; Korse, C.M.
Published
2018
Publication type
Article / Letter to editor
Risk-reducing salpingo-oophorectomyanti-Mullerian hormonemenopauseBRCA1/2menopausal symptomsovarian cancer
Date issued
2018-11-02
Language
English
Is part of
Climacteric (2018), Vol. 21, no. 6, p. 574-580
hdl
1887/86655
doi
10.1080/13697137.2018.1512965
URL
https://doi.org/10.1080/13697137.2018.1512965